SCHEDULE 13G

Company

Cardiff Oncology, Inc.

Filed

February 10, 2005

Accession Number

0001169232-05-000594

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →